NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
Reference ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323 · NHS England
Awarded to Biogen and 20 others. Estimated value: £4,108,145,000.
Interested in tenders like this? Get the next tenders like this one published in the United Kingdom by email. Free, no card needed.
Amounts and figures
Description
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Biogen | £986,282,758 | 1 July 2025 |
| Sobi (Swedish Orphan Biovitrum Ltd) | — | 1 July 2025 |
| Roche Products Ltd | — | 1 July 2025 |
| Fresenius Kabi Limited | — | 1 July 2025 |
| Sandoz Ltd | — | 1 July 2025 |
| Thornton and Ross Ltd | — | 1 July 2025 |
| Zentiva Pharma UK Ltd | — | 1 July 2025 |
| Accord-UK Ltd | — | 1 July 2025 |
| GlaxoSmithKline UK Limited | — | 1 July 2025 |
| Amgen Ltd | — | 1 July 2025 |
Official publications
| Medium | Reference | Date |
|---|---|---|
| FTS | cc644418-f584-45db-bf35-771baf03bc48-856590 | 29 July 2025 |
| Contracts Finder | cc644418-f584-45db-bf35-771baf03bc48-856590 | 29 July 2025 |
Other tenders from NHS England
See the buyer →- NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National Published: 24 July 2025
- NHS National Generic Pharmaceuticals - Clozapine Published: 16 July 2025
- NHS National Pharmaceuticals Generic Products Wave 15b Published: 17 February 2025
- NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Published: 20 January 2025
- NHS National Generic Pharmaceuticals Wave 15a Published: 18 December 2024
- NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 Published: 24 July 2024
- NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) Published: 14 May 2024
- NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2) Published: 14 May 2024
Similar open tenders
Frequently asked questions
- What is the deadline to bid for this tender?
- The submission deadline is 7 April 2025, 13:00. Check the official source, as dates can be modified.
- What is the estimated value of this tender?
- The estimated value published by the buyer is £4,108,145,000.
- Who is the buyer of this tender?
- The contracting authority is NHS England (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
How can I find out about similar tenders when they are published?
Create an account at el-vinculo.com and we give you a free month and set up your company's filters — contract type, CPV codes, value and territory — so you are the first to know when new tenders like this one come out in the United Kingdom. We email you as soon as one matching your profile is published, with the whole deadline ahead to prepare the bid.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.